Business Standard

'The fraud at Satyam is an accident'

Q&A: C B Bhave

C B Bhave
Related News

The Securities and Exchange Board of India Chairman C B Bhave today said at a press meet that Raju’s letter was not enough to put him in front of a magistrate and that the regulator will file a case against Satyam only after the investigation was complete. He also said that there was a need to assure investors that this was a one-off case.

On barring Price Waterhouse from the audit business
The investigations are going on. It is not right to blame one party or the other. We had nothing on hand apart from Raju’s letter 48 hours ago. Though yesterday was a holiday, a Sebi team visited Hyderabad to inspect the books of the company. Today the company’s chief financial officer spoke to the inspection team. The team has asked for Raju’s presence to question him. There will be a meeting with Raju tomorrow. We must wait for more evidence to come out.

On Sebi co-ordinating with US regulator Securities and Exchange Commission (SEC) to investigate the fraud
We have not sent any Sebi official to the US since the case falls in the Indian jurisdiction. But there will be co-ordinated action from both the regulators. The company has made a filing with the US SEC. We have a memorandum of understanding (MoU) with the SEC where we share information with each other.

On filing a case against Satyam
Action can be taken against the company under the Companies Act. Action can be taken under the Sebi Act or the Indian Penal Code (IPC). The police can take cognisance of the issue.

Failure of Clause 49 that stipulates the appointment of independent directors
The fraud at Satyam is an accident. After each accident, we must thoroughly investigate the cause.

Read more on:   
|
|

'The fraud at Satyam is an accident'

Q&A: C B Bhave

The Securities and Exchange Board of India Chairman C B Bhave today said at a press meet that Raju’s letter was not enough to put him in front of a magistrate and that the regulator will file a

The Securities and Exchange Board of India Chairman C B Bhave today said at a press meet that Raju’s letter was not enough to put him in front of a magistrate and that the regulator will file a case against Satyam only after the investigation was complete. He also said that there was a need to assure investors that this was a one-off case.

On barring Price Waterhouse from the audit business
The investigations are going on. It is not right to blame one party or the other. We had nothing on hand apart from Raju’s letter 48 hours ago. Though yesterday was a holiday, a Sebi team visited Hyderabad to inspect the books of the company. Today the company’s chief financial officer spoke to the inspection team. The team has asked for Raju’s presence to question him. There will be a meeting with Raju tomorrow. We must wait for more evidence to come out.

On Sebi co-ordinating with US regulator Securities and Exchange Commission (SEC) to investigate the fraud
We have not sent any Sebi official to the US since the case falls in the Indian jurisdiction. But there will be co-ordinated action from both the regulators. The company has made a filing with the US SEC. We have a memorandum of understanding (MoU) with the SEC where we share information with each other.

On filing a case against Satyam
Action can be taken against the company under the Companies Act. Action can be taken under the Sebi Act or the Indian Penal Code (IPC). The police can take cognisance of the issue.

Failure of Clause 49 that stipulates the appointment of independent directors
The fraud at Satyam is an accident. After each accident, we must thoroughly investigate the cause.

image

Read More

Emerging markets should continue to drive global growth: Jyotivardhan Jaipuria

With the government stepping on the reform pedal and the Reserve Bank of India (RBI) likely to cut rates, we expect a mild recovery in both the ...

Recommended for you

Quick Links

Market News

Nickel rises by 0.1% on Asian cues

Traders strengthened positions amid a firming Asian cues

Oil prices rise further in Asia

Expectations of a decline in US crude inventories and robust economic data from the eurozone helped prices

Markets remain rangebound; HUL up over 2%, Hindalco dips 1%

Investors are optimistic about a possible solution between Greece and its international creditors to avert a debt crisis

Pharma shares in focus; Aurobindo Pharma hits new high

JB Chemicals, Alembic Pharma, Aurobindo Pharma, Ipca Laboratories and Dishman Pharma were up 3%-11% each.

Infinite Computer gains on board approval for share buyback proposal

The stock spurted 5% at Rs 171 after the board approved the buyback of shares at a maximum price of Rs 220 per share from the open market ...

 

Back to Top